We aim to advance current state-of-the-art AI drug discovery technologies and transform high-cost, low-efficiency drug discovery practices into rapid, efficient discovery, ultimately leading to high success rates in the clinical phase.

Our award-winning AI drug discovery platform enables the direct discovery of high potency drugs that induce desired cellular-level activity with minimal off-target effects and toxicity.

AIGEN Sciences will revolutionize AI-based drug discovery.

AIGEN Sciences Inc.

Org chart

Teams

Offices